Brief: Vivos Therapeutics Says Received Notice From Nasdaq That Co Failed To Meet Minimum Bid Requirement
21/09/2023 22:54
Sept 21 (Reuters) - Vivos Therapeutics Inc VVOS.O :
* VIVOS THERAPEUTICS INC - RECEIVED NOTICE FROM NASDAQ THAT
CO
FAILED TO MEET MINIMUM BID REQUIREMENT
* VIVOS THERAPEUTICS INC - NASDAQ WOULD COMMENCE DELISTING
PROCEEDINGS AGAINST COMPANY
Further company coverage: VVOS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth